drugset / Trial / NCT05681182

Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone

NCT05681182

NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the combination of CardiaMend, with the addition of amiodarone in the prevention of postoperative atrial fibrillation (POAF) in patients undergoing isolated cardiac arterial bypass grafting (CABG) or valve surgery.

Timeline

Start
2023-01-20
Primary completion
2024-02-06
Completion
2024-02-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiodarone Small molecule 450 mg Intrathecal

Indications